Arimidex and Cisplatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arimidex (anastrozole) and Cisplatin (cisplatin). Common drug interactions include anxiety among females and abdominal abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Arimidex and Cisplatin. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Arimidex?

Arimidex has active ingredients of anastrozole. It is often used in breast cancer. eHealthMe is studying from 22,642 Arimidex users. Check the latest studies of Arimidex.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.



On Jul, 13, 2026

44 people who take Arimidex and Cisplatin together, and have interactions are studied.

Arimidex and Cisplatin drug interactions.

What are the common drug interactions of Arimidex and Cisplatin, by gender? *:

female:

  1. Anxiety
  2. Insomnia (sleeplessness)
  3. Pain
  4. Sinusitis (inflammation of sinus)
  5. Fatigue (feeling of tiredness)
  6. Dyspnoea (difficult or laboured respiration)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  9. Oedema peripheral (superficial swelling)
  10. Pain in jaw

male:

  1. Abdominal abscess (collection of pus in abdomen)
  2. Abdominal distension
  3. Atelectasis (partial or complete collapse of the lung)
  4. Bacteraemia (presence of bacteria in the blood)
  5. Bacterial sepsis
  6. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  7. Cardiac murmur (an heart sound in valve abnormality)
  8. Cardiac valve disease (heart valve disease)
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Cataract (clouding of the lens inside the eye)

What are the common drug interactions of Arimidex and Cisplatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug ineffective
  2. Disease progression

20-29:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Autoimmune hepatitis
  3. Intestinal obstruction
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Metastases to abdominal wall (cancer spreads to abdominal wall)
  6. Metastases to lung (cancer spreads to lung)
  7. Ovarian cancer metastatic (cancer of ovary spreads to other organ or parts)
  8. Peritoneal disorder
  9. Swelling
  10. Vulvovaginal swelling

30-39:

  1. Abdominal pain
  2. Adnexa uteri mass (ovarian cysts)
  3. Alopecia (absence of hair from areas of the body)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Back pain
  8. Blood creatine phosphokinase mb increased
  9. Bone disorder
  10. C-reactive protein increased

40-49:

  1. Metastases to bone (cancer spreads to bone)
  2. Anaemia (lack of blood)
  3. Anxiety
  4. Bone disorder
  5. Bone pain
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  8. Chest pain
  9. Conjunctivitis (pink eye)
  10. Decreased interest

50-59:

  1. Chest pain
  2. Confusional state
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Abdominal pain
  6. Ammonia increased
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Ataxia (loss of full control of bodily movements)
  9. Blood bilirubin increased
  10. Bone pain

60+:

  1. Abdominal hernia
  2. Oedema peripheral (superficial swelling)
  3. Anxiety
  4. Aspartate aminotransferase increased
  5. Bone disorder
  6. Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs)
  7. Malignant neoplasm progression (cancer tumour came back)
  8. Mass
  9. Metastases to adrenals (cancer spreads to adrenal gland of kidney)
  10. Metastases to lung (cancer spreads to lung)

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 13 people, 29.55%
  2. Metastases To Bone (cancer spreads to bone): 11 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Arimidex and Cisplatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arimidex and Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arimidex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arimidex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cisplatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on anastrozole and cisplatin (the active ingredients of Arimidex and Cisplatin, respectively), and Arimidex and Cisplatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: